Parmar Kush
- SEC CIK
- 0001664281
In the past year, 6 open-market sale filings worth $4.09M and no purchases.
Current role at each company
- SKYE Skye Bioscience, Inc.10% Owneras of Sep 24, 2026
- LTGO Latigo Biotherapeutics, Inc.10% Owneras of Aug 12, 2026
- TRDA Entrada Therapeutics, Inc.Directoras of Aug 10, 2026
- CAMP Camp4 Therapeutics Corp10% Owneras of Aug 5, 2026
- ARTV Artiva Biotherapeutics, Inc.10% Owneras of Jul 24, 2024
Show 7 more companies
- RLYB Rallybio CorpDirectoras of May 17, 2024
- ELVN Enliven Therapeutics, Inc.10% Owneras of Feb 16, 2024
- CINC CinCor Pharma, Inc.10% Owneras of Feb 28, 2023
- AKUS Akouos, Inc.Director, 10% Owneras of Dec 2, 2022
- QTTB Q32 Bio Inc.Directoras of Jun 17, 2022
- VOR Vor Biopharma Inc.Director, 10% Owneras of Jun 16, 2022
- CABA Cabaletta Bio, Inc.10% Owneras of Nov 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.09M
- 6 filings
- Net
- −$4.09M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Parmar Kush as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SKYE Skye Bioscience, Inc.
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 (view filing)4:29 PM ET | Sep 22-23 | 2 days | Rocklage Scott M and 7 others10% Owner | SSale | −148.1K | $1.62 | −$239.6K | −100.0%0 after | 4 lots |
| Sep 18, 2026 (view filing)6:37 PM ET | Sep 16 | 2 days | Rocklage Scott M and 7 others10% Owner | SSale | −33.9K | $1.91 | −$64.7K | −85.8%5.62K after | 2 lots |
| Aug 20, 2026 (view filing)5:57 PM ET | Aug 18-20 | 2 days | Rocklage Scott M and 7 others10% Owner | SSale | −375.8K | $0.3733 | −$140.3K | −4.6%7.85M after | 9 lots |
| Aug 22, 2025 (view filing)7:05 PM ET | Aug 21-22 | 1 day | Rocklage Scott M and 7 others10% Owner | SSale | −231.4K | $3.46 | −$800.5K | −80.1%57.5K after | 4 lotsDuplicate filing |
| Sep 13, 2024 (view filing)6:54 PM ET | Sep 11-13 | 2 days | Rocklage Scott M and 7 others10% Owner | SSale | −266.3K | $6.57 | −$1.75M | −80.1%66.3K after | 6 lotsDuplicate filing |
| Mar 15, 2024 (view filing)4:15 PM ET | Mar 13 | 2 days | Rocklage Scott M and 7 others10% Owner | PPurchase | +450.0K | $10.00 | +$4.50M | +5.7%8.39M after | |
| Feb 2, 2024 (view filing)4:32 PM ET | Jan 31 | 2 days | Rocklage Scott M and 7 others10% Owner | PPurchase | +5.21M | $2.31 | +$12.0M | +190.2%7.94M after |
TRDA Entrada Therapeutics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)7:54 PM ET | Aug 6-10 | 4 days | Parmar KushDirector | SSale | −155.3K | $6.95 | −$1.08M | −5.5%2.69M after | 3 lots |
| Aug 3, 2026 (view filing)5:26 PM ET | Jul 30-31 | 4 days | Parmar KushDirector, 10% Owner | SSale | −116.5K | $6.93 | −$807.0K | −3.9%2.85M after | 2 lots |
| Nov 18, 2025 (view filing) | Nov 14 | 4 days | Parmar KushDirector, 10% Owner | SSale | −200.0K | $8.80 | −$1.76M | −6.3%2.96M after | |
| Jul 11, 2025 (view filing) | Jul 9 | 2 days | Parmar KushDirector, 10% Owner | SSale | −27.0K | $7.50 | −$202.5K | −2.4%1.09M after | 2 lots |
| Jul 1, 2025 (view filing) | Jun 27-Jul 1 | 4 days | Parmar KushDirector, 10% Owner | SSale | −125.0K | $6.93 | −$866.5K | −10.2%1.10M after | 6 lots |
| Nov 5, 2021 (view filing) | Nov 2 | 3 daysLate | Parmar KushDirector, 10% Owner | PPurchase | +250.0K | $20.00 | +$5.00M | +28.3%1.13M after | Duplicate filing |
CAMP Camp4 Therapeutics Corp
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)5:39 PM ET | Aug 3 | 2 days | Parmar Kush and 6 others10% Owner | PPurchase | +3.18M | $1.53 | +$4.86M | –3.18M after | Derivative |
| Sep 15, 2025 (view filing)8:12 PM ET | Sep 11 | 4 days | Parmar Kush and 6 others10% Owner | PPurchase | +2.94M | $1.53 | +$4.50M | New position2.94M after | |
| Oct 15, 2024 (view filing)5:56 PM ET | Oct 15 | Same day | Parmar Kush and 4 others10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | +53.0%2.63M after | Duplicate filing |
ARTV Artiva Biotherapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2024 (view filing)4:15 PM ET | Jul 22 | 2 days | Schwab Andrew J. and 5 others10% Owner | PPurchase | +833.3K | $12.00 | +$10.0M | +239.0%1.18M after |
ELVN Enliven Therapeutics, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 (view filing)4:15 PM ET | Feb 14 | 2 days | Schwab Andrew J. and 5 others10% Owner | SSale | −825.0K | $14.90 | −$12.3M | −56.5%635.3K after | 2 lots |
| Feb 2, 2024 (view filing)4:29 PM ET | Jan 31 | 2 days | Schwab Andrew J. and 5 others10% Owner | SSale | −500.0K | $15.00 | −$7.50M | −39.3%772.0K after | 2 lots |
| Sep 28, 2023 (view filing)4:27 PM ET | Sep 26 | 2 days | Schwab Andrew J. and 5 others10% Owner | SSale | −197.5K | $15.00 | −$2.96M | −18.8%854.8K after | 2 lots |
| Aug 28, 2023 (view filing)4:20 PM ET | Aug 24 | 4 days | Schwab Andrew J. and 5 others10% Owner | SSale | −440.0K | $16.00 | −$7.04M | −33.1%887.5K after | 2 lots |
RLYB Rallybio Corp
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Parmar KushDirector | SSale | −100.0K | $8.20 | −$820.0K | −4.0%2.38M after | |
| Jun 7, 2022 (view filing) | Jun 3 | 4 days | Parmar KushDirector, 10% Owner | SSale | −150.0K | $12.50 | −$1.88M | −10.7%1.25M after | 2 lots |
| May 25, 2022 (view filing) | May 23 | 2 days | Parmar KushDirector, 10% Owner | SSale | −100.0K | $13.00 | −$1.30M | −7.1%1.30M after | 2 lots |
| Feb 10, 2022 (view filing) | Feb 8 | 2 days | Parmar KushDirector | SSale | −210.0K | $13.05 | −$2.74M | −13.6%1.34M after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Parmar KushDirector | PPurchase | +615.4K | $13.00 | +$8.00M | +77.8%1.41M after |
CINC CinCor Pharma, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 (view filing)8:01 PM ET | Aug 15 | 2 days | Schwab Andrew J. and 7 others10% Owner | PPurchase | +600.0K | $30.00 | +$18.0M | New position487.3K after | 2 lots |
| Jan 13, 2022 (view filing)4:45 PM ET | Jan 11 | 2 days | Schwab Andrew J. and 5 others10% Owner | PPurchase | +470.0K | $16.00 | +$7.52M | +1,785.5%496.3K after | 2 lots |
VOR Vor Biopharma Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Parmar KushDirector, 10% Owner | SSale | −330.7K | $15.30 | −$5.06M | −15.8%1.77M after | 2 lots |
CABA Cabaletta Bio, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2021 (view filing)4:38 PM ET | Nov 1 | 2 days | Rocklage Scott M and 6 others10% Owner | SSale | −295.0K | $13.00 | −$3.83M | −47.0%333.1K after | 2 lots |
| Sep 9, 2021 (view filing)5:34 PM ET | Sep 7 | 2 days | Rocklage Scott M and 6 others10% Owner | SSale | −625.0K | $9.70 | −$6.06M | −23.9%1.99M after |